Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joelle El-Amm

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Oncology|August 13, 2013
Emerging therapies in multiple myelomaJoelle El-Amm, Imad A Tabbara
Clinical Medicine Insights. Oncology|March 16, 2019
The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate CancerJoelle El-Amm, Jeanny B Aragon-Ching
Oncotargets and Therapy|June 10, 2015
Radium-223 for the treatment of castration-resistant prostate cancerJoelle El-Amm, Jeanny B Aragon-Ching
Therapeutic Advances in Medical Oncology|January 17, 2013
The changing landscape in the treatment of metastatic castration-resistant prostate cancerJoelle El-Amm, Jeanny B Aragon-Ching
Clinical Medicine Insights. Oncology|April 5, 2016
Targeting Bone Metastases in Metastatic Castration-Resistant Prostate CancerJoelle El-Amm, Jeanny B Aragon-Ching
Asian Journal of Andrology|October 25, 2017
Role of chemotherapy in prostate cancerRita Nader, Joelle El Amm, Jeanny B Aragon-Ching
Cancer Management and Research|July 27, 2017
Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectivesJoelle El-Amm, Rami Nassabein, Jeanny B Aragon-Ching
Prostate Cancer|September 27, 2013
Bone-targeted therapies in metastatic castration-resistant prostate cancer: evolving paradigmsJoelle El-Amm, Ashley Freeman, Nihar Patel, et al.
Clinical Medicine Insights. Oncology|November 2, 2013
Metastatic castration-resistant prostate cancer: critical review of enzalutamideJoelle El-Amm, Nihar Patel, Ashley Freeman, et al.
Cancer Investigation|June 6, 2014
Complications of allogeneic hematopoietic stem cell transplantationKarim Arnaout, Nihar Patel, Maneesh Jain, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Oncology|August 13, 2013
Emerging therapies in multiple myelomaJoelle El-Amm, Imad A Tabbara
Clinical Medicine Insights. Oncology|March 16, 2019
The Current Landscape of Treatment in Non-Metastatic Castration-Resistant Prostate CancerJoelle El-Amm, Jeanny B Aragon-Ching
Oncotargets and Therapy|June 10, 2015
Radium-223 for the treatment of castration-resistant prostate cancerJoelle El-Amm, Jeanny B Aragon-Ching
Therapeutic Advances in Medical Oncology|January 17, 2013
The changing landscape in the treatment of metastatic castration-resistant prostate cancerJoelle El-Amm, Jeanny B Aragon-Ching
Clinical Medicine Insights. Oncology|April 5, 2016
Targeting Bone Metastases in Metastatic Castration-Resistant Prostate CancerJoelle El-Amm, Jeanny B Aragon-Ching
Asian Journal of Andrology|October 25, 2017
Role of chemotherapy in prostate cancerRita Nader, Joelle El Amm, Jeanny B Aragon-Ching
Cancer Management and Research|July 27, 2017
Impact of abiraterone on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectivesJoelle El-Amm, Rami Nassabein, Jeanny B Aragon-Ching
Prostate Cancer|September 27, 2013
Bone-targeted therapies in metastatic castration-resistant prostate cancer: evolving paradigmsJoelle El-Amm, Ashley Freeman, Nihar Patel, et al.
Clinical Medicine Insights. Oncology|November 2, 2013
Metastatic castration-resistant prostate cancer: critical review of enzalutamideJoelle El-Amm, Nihar Patel, Ashley Freeman, et al.
Cancer Investigation|June 6, 2014
Complications of allogeneic hematopoietic stem cell transplantationKarim Arnaout, Nihar Patel, Maneesh Jain, et al.
Pageof 1